Thrombolysis for ischaemic stroke despite direct oral anticoagulation  

作　　者：Jan C.Purrucker Thomas R.Meine Duncan Wilson Ying Xian Teddy Y.Wu David J.Seiffge 

机构地区：[1]Department of Neurology,Heidelberg University Hospital,Heidelberg,Germany [2]Department of Neurology and Stroke Research Center Bern,Inselspital Bern,University of Bern,Bern,Switzerland [3]New Zealand Brain Research Institute,Christchurch,New Zealand [4]The University of Texas Southwestern Medical Center,Dallas,Texas,USA [5]Department of Neurology,Christchurch Hospital,Christchurch,New Zealand

出　　处：《Stroke & Vascular Neurology》2024年第5期464-466,共3页卒中与血管神经病学（英文）

摘　　要：Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants(DOACs)and a recent intake within the last 48hours in US and European guidelines.However,three observational studies now suggest safety of thrombolysis in patients with recent intake of DOACs,and thus support previous experimental data.In this perspective,the current evidence and practical consequences are discussed.

关 键 词：INTAKE PATIENTS consequences 

分 类 号：R743.3[医药卫生—神经病学与精神病学]